Oct 8 (Reuters) - Lifecare ASA LIFEA.OL :
* SCIENTIFIC TEAM HAS CONCLUDED THAT IMPLANT WAS STABLE OVER
PERIOD OF 12 WEEKS
* CONFIRMS NO UNEXPECTED TISSUE, BODY RESPONSE BASED ON
BACTERIOLOGICAL, BIOPSY TESTS AFTER REMOVAL OF IMPLANTED SENSOR
* IN-VITRO FUNCTIONALITY TESTS OF IMPLANT AFTER REMOVAL HAVE
SHOWN
THAT SENSOR IS FULLY GLUCOSE SENSITIVE
* PLAN TO INITIATE NEXT PHASE OF TESTING IN UPCOMING WEEKS
Source text for Eikon: ID:nMFN9sNjZC
Further company coverage: LIFEA.OL
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))